Clinical Trial Update: Impact of Intrathecal vs Intravenous Dexmedetomidine [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intrathecal versus intravenous dexmedetomidine for postoperative nausea and vomiting; recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Muhammad Ilyas | Conditions: Nausea and Vomiting, Postoperative | Phase 4 | Status: NOT_YET_RECRUITING